ROAMD Podcast

A New Era of Cardiovascular Risk Detection in Concierge Medicine

August 23, 2022 Scott Pope Season 2 Episode 10
A New Era of Cardiovascular Risk Detection in Concierge Medicine
ROAMD Podcast
More Info
ROAMD Podcast
A New Era of Cardiovascular Risk Detection in Concierge Medicine
Aug 23, 2022 Season 2 Episode 10
Scott Pope

One of the core tenants of every concierge medicine practice is prioritizing prevention over treatment. Getting in front of chronic illness before it becomes such creates a better patient experience, produces better outcomes, and ultimately reduces the overall costs for the entire healthcare system. The leading cause of death in the United States is still heart disease. Yes, even in the face of a pandemic, heart disease outpaced COVID-19 deaths by more than two-fold in 2020. My guest on this episode is the Founder and CEO of Cleerly Dr. Jim Min. Cleerly has created a predictive, personalized, and tracked approach to measure atherosclerosis, the true predictor of heart attacks.
In this episode, Dr. Min, a prolific contributor to the medical literature and board-certified cardiologist, shares his personal journey through the trenches of traditional medicine where the primary method for assessing heart attack risk isn't measuring actual disease itself but relying on surrogate markers. Jim's efforts through Cleerly aim to remedy this approach and truly give physicians and patients actual assessments of disease above and beyond just the status quo surrogate markers from the past. Whether you're a concierge physician or a patient of one, you will surely enjoy this episode.

Show Notes

One of the core tenants of every concierge medicine practice is prioritizing prevention over treatment. Getting in front of chronic illness before it becomes such creates a better patient experience, produces better outcomes, and ultimately reduces the overall costs for the entire healthcare system. The leading cause of death in the United States is still heart disease. Yes, even in the face of a pandemic, heart disease outpaced COVID-19 deaths by more than two-fold in 2020. My guest on this episode is the Founder and CEO of Cleerly Dr. Jim Min. Cleerly has created a predictive, personalized, and tracked approach to measure atherosclerosis, the true predictor of heart attacks.
In this episode, Dr. Min, a prolific contributor to the medical literature and board-certified cardiologist, shares his personal journey through the trenches of traditional medicine where the primary method for assessing heart attack risk isn't measuring actual disease itself but relying on surrogate markers. Jim's efforts through Cleerly aim to remedy this approach and truly give physicians and patients actual assessments of disease above and beyond just the status quo surrogate markers from the past. Whether you're a concierge physician or a patient of one, you will surely enjoy this episode.